Table 2 Clinical characteristics of included patients

Gender

0.500

 male

30(25.2%)

135(28.3%)

 female

89(74.8%)

342(71.7%)

Age

0.012

 ≥ 40 years

100(84.0%)

348(73.0%)

 < 40 years

19(16.0%)

129(27.0%)

BMI

0.402

 ≥ 28 kg/m²

7(5.9%)

39(8.2%)

 < 28 kg/m²

112(94.1%)

438(91.8%)

Symptoms

0.884

 Yes

53(44.5%)

216(45.3%)

 No

66(55.5%)

261(54.7%)

Comorbidities

0.229

 Yes

25(21%)

78(16.4%)

 No

94(79%)

399(83.6%)

History of abdominal surgery

0.833

 Yes

26(21.8%)

100(21.0%)

 No

93(78.2%)

377(79.0%)

Hepatitis B

0.877

 Yes

8(6.7%)

34(7.1%)

 No

111(93.3%)

443(92.9%)

Tumor size

< 0.001

 ≥ 9 cm

83(69.7%)

171(35.8%)

 < 9 cm

36(30.3%)

306(64.2%)

Tumor number

0.553

 Solitary

58(48.7%)

247(51.8%)

 Multiple

61(51.3%)

230(48.2%)

Location

0.219

 Left lobe

31(26.1%)

170(35.6%)

 Right lobe

58(48.7%)

192(40.3%)

 Bilateral

27(22.7%)

102(21.4%)

 Caudate lobe

3(2.5%)

13(2.7%)

 ALT, IU/L

15(11–23)

17(12–25)

0.978

 AST, IU/L

18(15–23)

18(15–23)

0.155

 ALB, g/L

44.1 ± 3.6

44.5 ± 3.7

0.350

 TB, μmol/L

13.2(11–16.7)

12.6(10.2–16.3)

0.118

 sCRE, μmol/L

80(70–87)

82(74.6–91)

0.032

 PLT, × 10⁹/L

187(150–235)

183(146–226)

0.688

 PT, s

11(10.6–11.6)

11.1(10.6–11.6)

0.715